4.8 Article

Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation

Journal

CELL REPORTS
Volume 10, Issue 9, Pages 1626-1638

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2015.02.012

Keywords

-

Categories

Funding

  1. Swedish Research Council
  2. A.E. Berger Foundation
  3. Bergvall Foundation
  4. Crafoord Foundation
  5. G. & J. Koch Foundation
  6. Gyllenstiernska Krapperup Foundation
  7. Karolinska Institute research grants
  8. Lars Hierta Memorial Foundation
  9. Proyecto de Excelencia from Junta de Andalucia [CTS-6494]
  10. Royal Physiographic Society
  11. Royal Physiographic Society in Lund Foundation
  12. Spanish Ministerio de Ciencia y Tecnologia [SAF2009-13778]
  13. Stohnes Foundation
  14. Swedish Cancer Society
  15. Swedish Research Council [2012-2229]
  16. Swedish Parkinson Foundation
  17. Swedish Strategic Research Area MultiPark at Lund University
  18. Swedish National Stroke Foundation
  19. Wiberg Foundation

Ask authors/readers for more resources

Inflammatory response induced by microglia plays a critical role in the demise of neuronal populations in neuroinflammatory diseases. Although the role of toll-like receptor 4 (TLR4) in microglia's inflammatory response is fully acknowledged, little is known about endogenous ligands that trigger TLR4 activation. Here, we report that galectin-3 (Gal3) released by microglia acts as an endogenous paracrine TLR4 ligand. Gal3-TLR4 interaction was further confirmed in a murine neuroinflammatory model (intranigral lipopolysaccharide [LPS] injection) and in human stroke subjects. Depletion of Gal3 exerted neuroprotective and anti-inflammatory effects following global brain ischemia and in the neuroinflammatory LPS model. These results suggest that Gal3-dependent-TLR4 activation could contribute to sustained microglia activation, prolonging the inflammatory response in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available